Pharmaceutical Updates

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its new state-of-the-art Technology Centre in Hyderabad, marking a significant milestone in...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio...

RPG Life Sciences Partners With Archerchem to Launch Naprosyn ES in India

RPG Life Sciences has announced a new collaboration with Archerchem Healthcare to bring Naprosyn ES, a first-of-its-kind fixed combination of Naproxen and Esomeprazole, to the Indian...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health and Family Welfare, has issued a...

​OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets

OneSource Speciality Pharma has entered into a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilar medicines for global markets, reinforcing India's growing role as...

Trump Announces Import Taxes on Generic Drugs to Boost US Manufacturing

US President Donald Trump has announced a new phased tariff policy targeting imported generic medicines, designed tostimulate biopharmaceutical companies to establish domestic manufacturing operations within the United...